However, activation of c-Jun NH2-terminal kinase (JNK) and p-JNK has not been studied in breast cancer undergoing NACT, and the expression and clinical role of p-JNK in breast cancer are unknown at present. Here, MAPK8 is linked to breast carcinoma.